跳至主要内容
临床试验/NCT04556864
NCT04556864Unknown不适用

Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to SARS-CoV-2 Infection

Juan Victor Lorente5 个研究点 分布在 1 个国家目标入组 67 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
67
试验地点
5
主要终点
Total amount of hypotension

研究概览

简要总结

The aim of the present work is to describe the hemodynamic effects shown in patients with ARDS secondary to SARS-CoV-2 infection

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years old.
  • Patients that are classified as a "confirmed case" according to criteria established by the Spanish Ministry of Health in its Technical Document updated on March 31,
  • This defines a "confirmed case" as a case that meets laboratory criteria (Positive PCR test for any of the SARS-CoV-2 genes).
  • Patients admitted to ICU.
  • Presence of Kirby index (PaFi) less than or equal to 300 mm Hg, with PEEP or CPAP greater than or equal to 5 cmH2O.
  • Need for radial artery cannulation for hemodynamic monitoring and/or repeated monitoring of blood gases at the discretion of the responsible physician.
  • Patients who agree (or a representative of the patient if sedated) to participate in study and who provide written informed consent.

排除标准

  • Patients being treated with veno-venous or veno-arterial ECMO
  • Patient with therapeutic restrictions due to life support
  • Patient who presents a complication that requires surgical intervention.

结局指标

主要结局

Total amount of hypotension

时间窗: 5 days

Hypotension will be defined as a hemodynamic event that occurs when the MAP falls below 65 mmHg for a minimum duration of 1 minute (3 consecutive recordings of 1 minute or more between two consecutive falls of the MAP).

次要结局

  • Acute kidney injury(Daily during 5 days)
  • Daily diuresis, daily water balance, accumulated water balance since ICU admission, daily parenteral nutrition volume, and daily enteral nutrition volume.(Daily during 5 days)
  • Atrial fibrillation(5 days)
  • Need for Hemadsorption(5 days)
  • Specific treatment for SARS-CoV2 (presence of tocilizumab, antimalarial drugs, antivirals)(5 days)
  • Continuous renal replacement therapies(5 days)
  • Corticoid treatment.(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (Stroke volume)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (Stroke volume variation)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (Cardiac index)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor ( HPI)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (Eadyn)(5 days)
  • Minimally invasive hemodynamic monitoring and related variables obteined from HemoSphere platform with Acumen IQ sensor (dp/dt max,)(5 days)
  • Presence of treatment with noradrenaline; presence of treatment with dobutamine, presence of treatment with other vasoactive/ionotropic/hypotensive drugs(5 days)
  • Furosemide treatment(Daily during 5 days)

研究者

发起方
Juan Victor Lorente
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Juan Victor Lorente

Medical Doctor

Andalusian Network for Design and Translation of Advanced Therapies

研究点 (5)

Loading locations...

相似试验